Cann Group Issues New Shares Under Convertible Securities Deal

Cann Group ( (AU:CAN) ) has shared an announcement.

Cann Group Limited has issued 8,416,667 fully paid ordinary shares to Obsidian Global GP, LLC under a previously announced convertible securities agreement, expanding its share capital base. The company stated that the issuance was conducted without a disclosure document under the Corporations Act but confirmed it remains compliant with financial reporting and continuous disclosure obligations and that there is no excluded information impacting investors.

This move reflects Cann Group’s ongoing use of structured financing to support its operations and growth initiatives in the medical cannabis market. The confirmation of regulatory compliance and absence of undisclosed material information aims to reassure shareholders and the market regarding transparency and governance around the new equity issuance.

The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.

More about Cann Group

Cann Group Limited is an Australian-listed company operating in the medical cannabis sector. The company focuses on cultivating and producing cannabis and cannabis-derived products for domestic and potentially international medicinal markets, positioning itself within the regulated pharmaceutical and healthcare supply chain.

Average Trading Volume: 12,112,118

Technical Sentiment Signal: Sell

Current Market Cap: A$11.12M

For detailed information about CAN stock, go to TipRanks’ Stock Analysis page.